arrow_back Back to App

New Drug Verification Methods: Safer Controlled Substances

This act introduces new rules for verifying the authenticity of certain medications, especially controlled substances. Starting in 2026, oral controlled substances will need to include special chemical identifiers to combat counterfeiting. This helps citizens feel safer, knowing the medications they take are genuine and secure.
Key points
As of January 1, 2026, oral controlled substances must include special, invisible chemical identifiers.
These identifiers will allow quick verification of a drug's authenticity, making it harder for counterfeit products to enter the market.
The act aims to increase the safety of medications available to citizens, minimizing the risk of purchasing fake products.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_7653
Sponsor: Rep. Mullin, Markwayne [R-OK-2]
Process start date: 2022-05-03
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Modern Authentication of Pharmaceuticals Act of 2022

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_7653.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-05-03.

What are the main provisions?

Key points include:

  • As of January 1, 2026, oral controlled substances must include special, invisible chemical identifiers.
  • These identifiers will allow quick verification of a drug's authenticity, making it harder for counterfeit products to enter the market.
  • The act aims to increase the safety of medications available to citizens, minimizing the risk of purchasing fake products.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Mullin, Markwayne [R-OK-2].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health